Enhancer (genetics)
Short DNA region that boosts gene transcription via activator proteins.
In genetics, an enhancer is a short stretch of DNA, usually between 50 and 1,500 base pairs long. Proteins known as activators bind to it to boost the chances that a specific gene will be transcribed. These activators are a type of transcription factor. Enhancers are cis-acting, meaning they influence nearby genes on the same DNA molecule, but they can be positioned up to one million base pairs away from their target gene, either before or after the transcription start site. The human genome contains hundreds of thousands of enhancers, and they are found exclusively in eukaryotes, not in prokaryotes. When an enhancer is active, it is typically transcribed into a non-coding RNA called enhancer RNA, and the amount of this RNA tends to match the mRNA levels of the target gene.
The first eukaryotic enhancer was discovered in 1981, located in the SV40 virus. This finding helped explain how certain viral genes were activated. In the context of immunoglobulin genes, the inactivity of unrearranged Vh promoters is primarily due to lack of V(D)J recombination bringing them near the enhancer, rather than the enhancer itself being the sole cause. More recently, enhancer mutations have been linked to various medical conditions, though myelosuppression is not a well-established specific genetic condition in canonical genetics literature. Starting in 2022, researchers have used artificial intelligence to design synthetic enhancers, first testing them in cell lines and then, a year later, in living animals.
In eukaryotic cells, DNA is folded into chromatin so that an enhancer, though far away in linear sequence, ends up spatially close to its gene’s promoter. This proximity lets it interact with general transcription factors and RNA polymerase II. Silencers work the same way but have the opposite effect: when bound by repressor proteins, they suppress transcription. Silencers and enhancers can sit right next to each other, sometimes in the same region, distinguished only by which transcription factor binds there.
An enhancer can be located upstream or downstream of its gene, and it does not have to be near the transcription start site—some are hundreds of thousands of base pairs away. Enhancers do not act directly on the promoter; instead, activator proteins bind them, as first shown by in vivo competition experiments. Later molecular studies revealed direct interactions
- first_discovery
- 1981 in the SV40 virus
Lore & Background
The first discovery of a eukaryotic enhancer occurred in 1981 within the SV40 virus. In the context of immunoglobulin genes, the inactivity of unrearranged Vh promoters is primarily due to lack of V(D)J recombination bringing them near the enhancer, rather than the enhancer itself being the sole cause. Enhancers are bound by activator proteins, as first shown by in vivo competition experiments, and later molecular studies demonstrated direct interactions with transcription factors and cofactors, including the mediator complex, which recruits RNA polymerase II. Enhancers can function regardless of orientation and can be excised and inserted elsewhere in the chromosome while still affecting gene transcription. They are bound by p300-CBP, and
Reader's Guide
Enhancers are fundamental to understanding gene regulation in both health and disease. They control cell-type-specific gene expression by looping over long distances to bring transcription factors and cofactors into proximity with target gene promoters. Multiple enhancers can coordinate to regulate a single gene, and their activity is often marked by the production of enhancer RNA. Enhancers have been implicated in medical conditions such as myelosuppression. Since 2022, scientists have used artificial intelligence to design synthetic enhancers, first in cell lines and later in vivo. The study of enhancers has been revolutionized by high-throughput methods like massively parallel reporter assays and chromatin accessibility assays. Two competing hypotheses—enhanceosomes and flexible billboards—describe how information processing occurs on enhancers, reflecting ongoing uncertainty in the field.
Did You Know?
- Enhancers can be located up to 1 million base pairs away from their target gene.
- Active enhancers are typically transcribed into enhancer RNA, whose levels correlate with target gene mRNA levels.
- The first eukaryotic enhancer was discovered in 1983 in the immunoglobulin heavy chain gene.
- Since 2022, artificial intelligence has been used to design synthetic enhancers, first in cell lines and later in vivo.
More in Genetics 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record